Related Experiment Video
Updated: May 7, 2026
08:18
Non-Aqueous Isolation and Enrichment of Glandular Capitate Stalked and Sessile Trichomes from Cannabis sativa
Published on: May 12, 2023
2.9K
Mastering tricyclic ring systems for desirable functional cannabinoid activity.
Ravil R Petrov1, Lindsay Knight, Shao-Rui Chen
1Core Laboratory for Neuromolecular Production, Department of Biomedical and Pharmaceutical Sciences, The University of Montana, Missoula, MT 59812, USA.
European Journal of Medicinal Chemistry
|October 16, 2013
Summary
Researchers developed novel carbazole and γ-carboline compounds targeting cannabinoid receptors for pain. Compound 64, a selective CB2 agonist, effectively reduced neuropathic pain in rats, showing potential for pain treatment.
Area of Science:
- Medicinal Chemistry
- Neuropharmacology
- Pain Research
Background:
- Growing interest in cannabinoid receptor 2 (CB2) agonists for treating neuropathic pain.
- Need for novel small molecule cannabinoid ligands with improved selectivity and efficacy.
Purpose of the Study:
- Synthesize and characterize novel carbazole and γ-carboline derivatives as cannabinoid receptor ligands.
- Investigate structure-activity relationships to identify selective CB2 agonists for pain management.
Main Methods:
- Competitive radioligand displacement assays for human CB2 and rat CB1 receptors.
- Receptor internalization and [(35)S]GTP-γ-S assays to assess functional activity and selectivity.
- Evaluation of compound efficacy in a rat model of neuropathic pain.
Main Results:
- Discovery of non-selective agonist (compound 4) and development of CB2-selective compounds (64, 63, 68).
- Compound 64 demonstrated potent CB2 receptor internalization and significant reduction in neuropathic pain hypersensitivity.
- Identification of a selective CB1 agonist (compound 74) and a high-affinity CB2 ligand with unique functional properties (compound 35).
Conclusions:
- Novel tricyclic carbazole and γ-carboline series offer a promising starting point for CB2 pharmacology research.
- Compound 64 represents a potential therapeutic candidate for neuropathic pain treatment.
- The study highlights the potential of targeting CB2 receptors for effective pain relief.
Keywords:
BSACB1CB2CannabinoidCarbazoleEC(50)EDTAGPCRGTPIC(50)Neuropathic painVZAFOXSCFBBHKO-UHFFFAOYSA-Nbovine serum albumincannabinoid receptor 1cannabinoid receptor 2ethylenediaminetetraacetic acidguanosine-5′-triphosphatehCB1hCB2half maximal effective concentrationhuman CB1human CB2median inhibition concentration
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.5K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.5K
01:25Analgesia and Pain Management
3.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.4K
02:33Stereoisomerism of Cyclic Compounds
9.3K
In this lesson, we delve into the role of ring conformation and its stability, which determines the spatial arrangement and, consequently, the molecular symmetry and stereoisomerism of cyclic compounds. 1,2-Dimethylcyclohexane is used as a case study to evaluate the possible number of stereoisomers. Here, given the multiple (n = 2) chiral centers, there are 2n = 4 possible configurations that lack a plane of symmetry, as the ring skeleton exists in a non-planar chair conformation. In addition,...
9.3K
01:22Opioid Receptors: Overview
7.4K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.4K
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K